Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 28,391

Document Document Title
WO/2014/066613A3
Sphingolipid metabolite mimetics and methods of synthesizing them are provided. The sphingolipid metabolite mimetics are shown to be effective at inducing apoptosis in various types of tumor cells. Further, the sphingolipid metabolite mi...  
WO/2014/063597A1
Disclosed is a cycloalkylamine compound of formula (I) useful in resisting mutant influenza virus, wherein n is independently selected from 0, 1; R1 is selected from H, alkyl, cycloalkyl, heterocyclic alkyl, aryl, imidazolyl, heteroaryl,...  
WO/2014/065382A1
Provided is a high-yield, high-selectivity method for manufacturing a difluoro compound without generating poorly soluble byproducts. An ester compound represented by formula (1) is reacted with an electrophilic fluorinating agent in the...  
WO/2014/063333A1
Disclosed in the present invention is a continuous production method of 2-MeTHF (2-methyltetrahydrofuran). The method comprises the following steps: inputting gasified furfural and hydrogen into a first reaction area and conducting prima...  
WO/2014/064318A1
The invention relates to a method for producing tetrahydrofurfuryl ethers, characterised in that it involves carrying out consecutive etherification/reduction reactions based on a compound containing at least one furan ring, in the prese...  
WO/2014/065391A1
The invention addresses the problem of providing a benzofluorene compound exhibiting excellent performance when used, e.g., in an organic electroluminescent element. A luminescent element having an exceptional element service life can be...  
WO/2014/064070A1
The invention relates to a process for regenerating a catalyst used in the decarbonylation of an aldehyde, wherein the catalyst is a heterogeneous, supported catalyst containing a metal selected from the group consisting of Fe, Ru, Os, C...  
WO/2014/063199A1
Novel benzofuran derivatives are disclosed. The derivatives have S1P1 receptor activity and/or disease modifying activity and find use in the treatment of conditions or diseases associated with the immune, vascular and nervous systems in...  
WO/2014/066746A1
The present disclosure provides methods to produce 5-(halomethyl)furfural, including 5- (chloromethyl)furfural, by acid-catalyzed conversion of biomass. The methods make use of certain organic solvents with temperature-dependent solubili...  
WO/2014/061731A1
The present invention pertains to a method that is for producing tetrahydrofuran and that, when obtaining tetrahydrofuran by supplying 1,4-butanediol to a reaction vessel and performing a cyclodehydration reaction in the presence of an a...  
WO/2014/061004A2
The present invention provides a novel intermediate of vilazodone and its process of preparation. The present invention further provides a process for preparing vilazodone or a pharmaceutically acceptable salt thereof using said novel in...  
WO/2014/060408A1
The invention relates to compounds of the general formula (I) in which R1 is a hydrogen atom, a hydroxy or methoxy group, a halogen atom, or an NO2 group; R2 is a hydrogen atom, a hydroxy or methoxy group, or an acyl or aroyl group; R3 i...  
WO/2014/061470A1
Provided are: a method for producing an N,N-dialkylhomofarnesic acid amide, which is a precursor of (±)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan that is useful as a fragrance, with a high raw material recovery ratio, high pur...  
WO/2014/062303A2
The present invention describes methods and apparatuses for the synthesis of 5-(chloromethyl)-2-furaldehyde (CMF) from monosaccharides, the method comprising: (a) contacting monosaccharides, hydrochloric acid, and an organic solvent, by ...  
WO/2014/061963A1
The present invention relates to an organic electroluminescence compound and an organic electroluminescence device containing the same. Using the organic electroluminescence compound according to the present invention, it is possible to ...  
WO/2014/061004A3
The present invention provides a novel intermediate of vilazodone and its process of preparation. The present invention further provides a process for preparing vilazodone or a pharmaceutically acceptable salt thereof using said novel in...  
WO/2014/061000A1
The present invention provides a novel intermediate of vilazodone and its process of preparation. The present invention further provides a process for preparing vilazodone or a pharmaceutically acceptable salt thereof using the novel int...  
WO/2014/058859A3
Described is a process to produce hydroxymethyl furfural (HMF) from biomass- derived sugars. The process includes the steps of reacting a C5 and/or C6 sugar- containing reactant derived from biomass in a monophasic or biphasic reaction s...  
WO/2014/056442A1
Disclosed in the invention is a single configuration(2R)-2-deoxy-2,2-disubstitute-1,4-ribose lactone and preparation method and use thereof. The (2R)-2-deoxy-2,2-disubstitute-1,4-ribose lactone of the following general formula V provided...  
WO/2014/058078A1
Disclosed is a process for preparing dihydro-2H-pyran derivatives of formula I: wherein R1 and R2 are defined herein. The process of the invention provides the compound of formula I in concise cascade reactions and in one pot. The compou...  
WO/2014/056410A1
The present invention relates to the crystalline form of sphaelactone dimethylamine fumarate of formula (I) and the preparation method. The preparation method of the crystalline form operates simply, can easily be industrialized, and emp...  
WO/2014/058859A2
Described is a process to produce hydroxymethyl furfural (HMF) from biomass- derived sugars. The process includes the steps of reacting a C5 and/or C6 sugar- containing reactant derived from biomass in a monophasic or biphasic reaction s...  
WO/2014/054785A2
The present invention provides an in-plane switching-type liquid crystal display element imparted with a high-efficiency alignment control function, and having excellent burn-in properties. The present invention also provides a manufactu...  
WO/2014/054410A1
The present invention provides an indeno[l,2- b] phenanthrene compound having suppressed hole transport ability. The indeno [1, 2-b] phenanthrene compound represented by the general formula [1] described in Claim 1 is provided. In the fo...  
WO/2014/054785A3
The present invention provides an in-plane switching-type liquid crystal display element imparted with a high-efficiency alignment control function, and having excellent burn-in properties. The present invention also provides a manufactu...  
WO/2014/049276A1
The present invention relates to a method for synthesising 2,5-furandicarboxylic acid (FDCA) from furan-2,5-dialdehyde (DFF). Said method is industrially applicable due to the simplicity and availability of the reagents used, and due to ...  
WO/2014/049275A1
The present invention relates to a method for selective hydrogenation of furan-2,5-dialdehyde (DFF) into 2,5-di(hydroxymethyl)furan (DHMF) and into 2,5-di(hydroxymethyl)tetrahydrofuran (DHMTHF). In relation to the prior art, which uses C...  
WO/2014/050894A1
The present invention provides the compound represented by formula (1) (in the formula: X1 and X2 each independently represent -OR1, -NR2R3, -CR4R5R6, or the like; R1, R2, R3, R4, R5, and R6 each independently represent a glycosyl group ...  
WO/2014/048547A1
The present invention relates to alpha hydroxy amides including compounds of formula (I) and related compounds and their use in the prophylaxis and treatment of inflammatory disorders and diseases, wherein T1, T2, W and Rw has the meanin...  
WO/2014/046097A1
The present invention is a photoresist composition which contains: a polymer that has a structural unit containing an acid-cleavable group; and an acid generator that contains a compound represented by formula (1). In formula (1), R1 rep...  
WO/2014/043793A1
Provided are methods for identifying or monitoring a subject having, or at risk of developing, impaired glucose homeostasis. Carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) is shown to be a biomarker for impaired glucose homeostas...  
WO/2014/037349A1
The invention relates to the use of substituted 2,3-dihydro-1-benzofuran-4-carboxylic acids of general formula (I) or the salts thereof, the groups in general formula (I) corresponding to the definitions cited in the description, for inc...  
WO/2014/037560A1
The invention provides a process to separate levulinic acid from a composition obtained by acid hydrolysis of biomass said process comprising subjecting said composition to solvent-solvent extraction to yield an organic phase comprising ...  
WO/2014/039638A1
The present invention relates to the energy efficient and selective extraction of dilute concentrations of biomolecules, e.g., small organic compounds, e.g., one or more C2-C6 alcohols, one or more C3-C5 carboxylic acids, one or more C8-...  
WO/2014/038221A1
The present invention provides: a method that is for preparing a crystal structure analysis sample resulting from an organic compound molecule that determines molecular structure being regularly arranged within hollows and minute pores w...  
WO/2014/037077A1
The present invention relates to connections which are suitable for use in electronic devices, preferably organic electroluminescence devices.  
WO/2014/038220A1
The present invention is: a guest-compound-enveloping polymer-metal-complex crystal characterized by at least one selected from an aliphatic hydrocarbon, an alicyclic hydrocarbon, an ether, an ester, an aromatic hydrocarbon, a halogenate...  
WO/2014/034190A1
The present invention is a radiation-sensitive resin composition, which contains an acid-cleavable group-containing polymer, a radiation-sensitive acid generator and a solvent, and wherein the radiation-sensitive acid generator contains ...  
WO/2014/033289A1
A process for the production of furan derivatives from carbohydrates in the presence of an acidic catalyst, characterized in that N-methylpyrrolidone is used as a solvent and that the acidic catalyst is homogeneous.  
WO/2014/034791A1
Provided is an organic electroluminescent element having the following positioned between a positive electrode and a negative electrode facing each other, in order from the negative-electrode side: a first hole transport layer, an adjace...  
WO/2014/035240A4
The present invention is in the field of a process for producing an ester, such as a biobased ester, from an aqueous biomass comprising solution, batch wise or continuously, wherein use of raw material is limited and if possible re-used....  
WO/2014/034893A1
This organic electroluminescent element comprises a negative electrode, a positive electrode, and one or more organic layers that are arranged between the negative electrode and the positive electrode and include at least a light emittin...  
WO/2014/034795A1
An aromatic amine derivative represented by formula (1) is useful as a constituent component in an organic EL element, and makes it possible to achieve an organic EL element which exhibits high efficiency and long life even when low-volt...  
WO/2014/033122A1
The present invention relates to compounds acting as selective inhibitors of CD40-TRAF6 interaction, their use as medicaments and their use in the treatment of (chronic) inflammatory diseases. The present invention also relates to pharma...  
WO/2014/034793A1
An aromatic amine derivative represented by formula (1) is useful as a constituent component in an organic EL element, and makes it possible to achieve an organic EL element which exhibits high efficiency and long life even when low-volt...  
WO/2014/035240A1
The present invention is in the field of a process for producing an ester, such as a biobased ester, from an aqueous biomass comprising solution, batch wise or continuously, wherein use of raw material is limited and if possible re-used....  
WO/2014/035813A1
Disclosed is a process to produce a dry purified carboxylic acid product comprising furan-2,5-dicarboxylic acid (FDCA). The process comprises oxidizing at least one oxidizable compound selected from the following group: 5-(hydroxymethyl)...  
WO/2014/031784A1
Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating...  
WO/2014/028342A1
The present disclosure provides processes for the preparation of a compound of Formula I: which is useful as an antiviral agent. The disclosure also provides compounds that are synthetic intermediates to compounds of formula.  
WO/2014/027676A1
An organic electroluminescence element in which a first organic layer and a luminous layer containing a luminous material are provided between a positive electrode and a negative electrode in order from the positive electrode side, where...  

Matches 151 - 200 out of 28,391